David Vaudry Selected Research

3- (2- chloro- 6- fluorobenzyl)- imidazolidine- 2,4- dione

10/2019

PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Vaudry Research Topics

Disease

14	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 06/2008
7	Ischemia 10/2021 - 11/2008
6	Stroke (Strokes) 01/2021 - 11/2006
5	Neoplasms (Cancer) 01/2022 - 03/2010
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
4	Fetal Alcohol Spectrum Disorders 12/2021 - 04/2002
4	Pheochromocytoma 07/2021 - 10/2002
4	Infarction (Infarctions) 01/2020 - 11/2006
4	Inflammation (Inflammations) 07/2015 - 03/2010
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 11/2006
2	Brain Injuries (Brain Injury) 10/2021 - 05/2012
2	Cognitive Dysfunction 01/2020 - 10/2015
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 11/2013
2	Anorexia 01/2018 - 01/2018
2	Neuroblastoma 04/2016 - 01/2016
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2015 - 01/2015
2	Colitis 07/2015 - 11/2013
2	Brain Ischemia (Cerebral Ischemia) 11/2014 - 11/2006
1	Body Weight (Weight, Body) 12/2021
1	Epilepsy (Aura) 10/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Neurobehavioral Manifestations 10/2019
1	Schizophrenia (Dementia Praecox) 10/2019
1	Catalepsy 10/2019
1	Diarrhea 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Binge Drinking 11/2017
1	Cerebellar Diseases (Cerebellar Syndrome) 06/2017
1	Alcoholism (Alcohol Abuse) 06/2017
1	Central Nervous System Diseases (CNS Diseases) 04/2016
1	Human Influenza (Influenza) 06/2015
1	Nervous System Mercury Poisoning (Minamata Disease) 04/2015
1	Respiratory Hypersensitivity 01/2015
1	Asthma (Bronchial Asthma) 01/2015

Drug/Important Bio-Agent (IBA)

28	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2021 - 04/2002
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2008
5	Ethanol (Ethyl Alcohol)IBA 12/2021 - 04/2002
5	NeuropeptidesIBA 10/2021 - 10/2007
5	Neuroprotective AgentsIBA 01/2021 - 10/2007
4	ProteomeIBA 01/2019 - 03/2010
3	AntioxidantsIBA 01/2020 - 03/2010
3	Ubiquitinated ProteinsIBA 01/2019 - 11/2013
3	Caspase 3 (Caspase-3)IBA 11/2014 - 05/2011
2	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 06/2011
2	Glutamic Acid (Glutamate)FDA Link 10/2019 - 01/2011
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2015 - 11/2013
2	Sulfonic AcidsIBA 07/2015 - 11/2013
2	UbiquitinIBA 07/2015 - 11/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011 - 05/2011
2	Messenger RNA (mRNA)IBA 06/2011 - 08/2006
1	GalaninIBA 10/2021
1	Thr(6)-Trp(8,9)-15-ol galanin (1-15)IBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2021
1	LigandsIBA 01/2021
1	HydrogelsIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2020
1	diazepam binding inhibitor (33-50)IBA 01/2020
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 01/2020
1	3- (2- chloro- 6- fluorobenzyl)- imidazolidine- 2,4- dioneIBA 10/2019
1	Apomorphine FDA Link 10/2019
1	ImidazolidinesIBA 10/2019
1	Ketamine FDA LinkGeneric 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 10/2019
1	HerbicidesIBA 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	ParaquatIBA 01/2019
1	Matrix Metalloproteinase InhibitorsIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 06/2017
1	Pharmaceutical PreparationsIBA 06/2017
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2016
1	Trinitrotoluene (TNT)IBA 11/2015
1	Purinergic Receptors (Receptors, Purine)IBA 10/2015
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2015
1	Glutamine (L-Glutamine)FDA Link 07/2015
1	AntigensIBA 06/2015
1	Polysaccharides (Glycans)IBA 06/2015
1	VaccinesIBA 06/2015
1	LipidsIBA 06/2015
1	Cyclic NucleotidesIBA 04/2015
1	Monoclonal AntibodiesIBA 01/2015
1	ammonium metavanadateIBA 01/2015
1	Vanadates (Orthovanadate)IBA 01/2015
1	VanadiumIBA 01/2015

Therapy/Procedure

1	Radiotherapy 01/2022
1	Axotomy 10/2021
1	Therapeutics 01/2021
1	Treatment Delay 01/2021
1	Transplantation 01/2020
1	Intranasal Administration 01/2020
1	Traditional Medicine (Folk Remedies) 04/2016
1	Enema (Enemas) 07/2015